Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 9.0B | 9.1B | 7.2B | 6.8B |
Cost of revenue | 7.0B | 7.1B | 5.8B | 5.2B |
Gross profit | 2.0B | 2.0B | 1.4B | 1.6B |
Operating expense | ||||
Research & development | 314.0M | 293.9M | 376.2M | 281.0M |
Selling general and admin | -32.4M | 823.5M | -986.2M | 1.7B |
Other operating expenses | 58.0M | 42.5M | 83.4M | 43.9M |
Operating income | 861.9M | 912.8M | 332.9M | 468.5M |
Non operating interest income | ||||
Income | 59.3M | 54.7M | 55.3M | 57.2M |
Expense | 84.5M | 78.0M | 64.6M | 73.0M |
Other income expense | — | — | — | — |
Pretax income | 587.9M | 802.4M | 79.2M | 363.7M |
Tax provision | 79.0M | 159.0M | 50.1M | 22.7M |
Net income | 508.9M | 643.4M | 29.2M | 341.0M |
Basic EPS | — | 0.3 | — | — |
Diluted EPS | — | 0.3 | — | — |
Basic average shares | — | 2.0B | — | — |
Diluted average shares | — | 2.3B | — | — |
EBITDA | 954.9M | 1.0B | 327.0M | 523.4M |
Net income from continuing op. | — | — | — | — |
Minority interests | 63.9M | 13.8M | -22.7M | -3.9M |
Preferred stock dividends | 0 | 0 | 0 | 0 |